Dr. Aude Segaliny, PhDVP of Research & Development at Amberstone BiosciencesSpeaker
Profile
Dr. Aude Segaliny, founding scientist and VP of R&D at Amberstone Biosciences, pioneers next-generation therapeutics designed for greater precision and a significantly improved therapeutic window. Her work focuses on delivering safer, highly potent treatments that push beyond current standards of care.
Agenda Sessions
Rewriting the Safety–Efficacy Balance: Engineering Conditionally Activated TCEs for Solid Tumors.
, 5:45pmView Session
